Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-192-5p ABCA8 2.1 0.00233 -0.99 0.28561 miRNAWalker2 validate -0.45 0 NA
2 hsa-miR-103a-2-5p ABCD2 -2.06 0.00116 -1.98 0.01409 MirTarget -0.26 0.00558 NA
3 hsa-miR-142-3p ABHD11 -2.4 4.0E-5 0.87 0.03845 miRanda -0.18 0.00067 NA
4 hsa-miR-142-3p ABHD12 -2.4 4.0E-5 0.22 0.40184 miRanda -0.15 0 NA
5 hsa-miR-103a-2-5p ABL2 -2.06 0.00116 -0.13 0.63539 MirTarget -0.13 6.0E-5 NA
6 hsa-miR-141-5p ABL2 2.11 0.00092 -0.13 0.63539 MirTarget; miRNATAP -0.14 1.0E-5 NA
7 hsa-miR-200a-5p ABL2 2.65 1.0E-5 -0.13 0.63539 mirMAP -0.16 0 NA
8 hsa-miR-194-3p ACAD11 2.07 0.00253 -0.57 0.03547 MirTarget -0.11 0.00017 NA
9 hsa-miR-192-5p ACSL1 2.1 0.00233 -0.25 0.53807 miRNAWalker2 validate -0.15 0.00051 NA
10 hsa-miR-142-3p ACTR3B -2.4 4.0E-5 0.29 0.32393 miRanda -0.1 0.00359 NA
11 hsa-miR-141-5p ACVRL1 2.11 0.00092 -0.37 0.23741 MirTarget -0.23 0 NA
12 hsa-miR-194-3p ADAM11 2.07 0.00253 -0.08 0.89144 mirMAP -0.22 0.00035 NA
13 hsa-miR-103a-2-5p ADAM22 -2.06 0.00116 -0.88 0.25527 mirMAP -0.31 0.00069 NA
14 hsa-miR-194-3p ADAMTS15 2.07 0.00253 0.16 0.85349 MirTarget -0.38 2.0E-5 NA
15 hsa-miR-194-5p ADAMTS5 2.55 0.00024 -0.73 0.15695 mirMAP -0.22 3.0E-5 NA
16 hsa-miR-192-5p ADARB1 2.1 0.00233 -0.6 0.08985 mirMAP -0.26 0 NA
17 hsa-miR-141-5p ADCY1 2.11 0.00092 -0.03 0.96543 mirMAP -0.24 0.0093 NA
18 hsa-miR-200a-5p ADD2 2.65 1.0E-5 -1.1 0.14442 mirMAP -0.53 0 NA
19 hsa-miR-192-5p AFAP1 2.1 0.00233 0.11 0.75207 mirMAP -0.1 0.0041 NA
20 hsa-miR-192-5p AFAP1L1 2.1 0.00233 -0.13 0.74099 miRNAWalker2 validate -0.27 0 NA
21 hsa-miR-141-5p AFF2 2.11 0.00092 -0.79 0.24367 mirMAP -0.34 1.0E-5 NA
22 hsa-miR-192-5p AFF2 2.1 0.00233 -0.79 0.24367 mirMAP -0.23 0.00104 NA
23 hsa-miR-194-3p AFF2 2.07 0.00253 -0.79 0.24367 MirTarget -0.17 0.01833 NA
24 hsa-miR-194-5p AFF2 2.55 0.00024 -0.79 0.24367 mirMAP -0.19 0.00694 NA
25 hsa-miR-141-5p AFF3 2.11 0.00092 -0.98 0.22174 mirMAP -0.43 0 NA
26 hsa-miR-200a-5p AFF3 2.65 1.0E-5 -0.98 0.22174 MirTarget -0.44 0 NA
27 hsa-miR-142-3p AGXT -2.4 4.0E-5 1.09 0.31324 miRanda -0.31 0.02223 NA
28 hsa-miR-141-5p AIF1L 2.11 0.00092 -1.32 0.02648 MirTarget -0.31 0 NA
29 hsa-miR-142-3p AK5 -2.4 4.0E-5 0.41 0.61895 miRanda -0.33 0.00111 NA
30 hsa-miR-200a-5p AKAP2 2.65 1.0E-5 -0.87 0.26357 mirMAP -0.22 0.0164 NA
31 hsa-miR-103a-2-5p AKR1C1 -2.06 0.00116 -0.93 0.17886 mirMAP -0.27 0.00074 NA
32 hsa-miR-142-3p AKT1S1 -2.4 4.0E-5 0.36 0.14789 MirTarget; miRanda; miRNATAP -0.15 0 NA
33 hsa-miR-192-5p ALCAM 2.1 0.00233 0.09 0.85523 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.12 0.02294 21119604 MicroRNA 192 and 215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro; Both transfection of mimics of microRNA-192 or -215 and ALCAM knockdown by an ALCAM-specific siRNA significantly increased the migration of HFE145 cells
34 hsa-miR-103a-2-5p ALDH1L2 -2.06 0.00116 0.27 0.69125 mirMAP -0.34 1.0E-5 NA
35 hsa-miR-194-3p ALDH1L2 2.07 0.00253 0.27 0.69125 MirTarget -0.28 8.0E-5 NA
36 hsa-miR-194-5p ALDH1L2 2.55 0.00024 0.27 0.69125 mirMAP -0.31 1.0E-5 NA
37 hsa-miR-142-3p AMN1 -2.4 4.0E-5 0.09 0.76433 miRanda -0.15 3.0E-5 NA
38 hsa-miR-192-5p AMOTL1 2.1 0.00233 -0.52 0.23224 mirMAP -0.29 0 NA
39 hsa-miR-141-5p AMZ1 2.11 0.00092 -0.84 0.19343 mirMAP -0.28 0.00012 NA
40 hsa-miR-194-3p AMZ1 2.07 0.00253 -0.84 0.19343 mirMAP -0.28 3.0E-5 NA
41 hsa-miR-144-5p ANG -2.21 0.00517 1.15 0.04302 MirTarget -0.14 0.00945 NA
42 hsa-miR-194-5p ANGPTL1 2.55 0.00024 -0.94 0.28852 MirTarget -0.43 0 NA
43 hsa-miR-194-3p ANGPTL6 2.07 0.00253 -1.69 0.01351 MirTarget -0.29 5.0E-5 NA
44 hsa-miR-192-5p ANKRD6 2.1 0.00233 -0.42 0.28815 miRNAWalker2 validate -0.16 0.00014 NA
45 hsa-miR-194-3p ANTXR1 2.07 0.00253 -0.08 0.90778 MirTarget -0.23 0.00113 NA
46 hsa-miR-103a-2-5p ANTXR2 -2.06 0.00116 0.45 0.35344 MirTarget -0.18 0.00119 NA
47 hsa-miR-141-5p AP1S2 2.11 0.00092 -0.98 0.02184 MirTarget -0.36 0 NA
48 hsa-miR-192-5p AP1S2 2.1 0.00233 -0.98 0.02184 miRNAWalker2 validate -0.27 0 NA
49 hsa-miR-215-5p AP1S2 3.07 0.00158 -0.98 0.02184 miRNAWalker2 validate -0.13 8.0E-5 NA
50 hsa-miR-192-5p APOLD1 2.1 0.00233 0.05 0.92161 miRNAWalker2 validate -0.29 0 NA
51 hsa-miR-194-3p APOLD1 2.07 0.00253 0.05 0.92161 MirTarget -0.25 1.0E-5 NA
52 hsa-miR-215-5p APOLD1 3.07 0.00158 0.05 0.92161 miRNAWalker2 validate -0.18 0 NA
53 hsa-miR-200a-5p AR 2.65 1.0E-5 -0.52 0.55352 miRNATAP -0.22 0.03873 24391862 We identified miR-200 b as a downstream target of androgen receptor and linked its expression to decreased tumorigenicity and metastatic capacity of the prostate cancer cells
54 hsa-miR-142-3p ARF5 -2.4 4.0E-5 0.16 0.49632 miRanda -0.13 0 NA
55 hsa-miR-141-5p ARHGAP19 2.11 0.00092 -0.39 0.08267 mirMAP -0.12 0 NA
56 hsa-miR-192-5p ARHGAP19 2.1 0.00233 -0.39 0.08267 miRNAWalker2 validate -0.11 1.0E-5 NA
57 hsa-miR-192-5p ARHGAP29 2.1 0.00233 -0.8 0.07773 miRNAWalker2 validate -0.21 1.0E-5 NA
58 hsa-miR-215-5p ARHGAP29 3.07 0.00158 -0.8 0.07773 miRNAWalker2 validate -0.11 0.0008 NA
59 hsa-miR-192-5p ARID5B 2.1 0.00233 -0.68 0.07996 mirMAP -0.23 0 NA
60 hsa-miR-142-3p ARL1 -2.4 4.0E-5 0.29 0.19981 miRanda; miRNATAP -0.14 0 NA
61 hsa-miR-192-5p ARL4C 2.1 0.00233 -0.63 0.25561 miRNAWalker2 validate -0.29 0 NA
62 hsa-miR-215-5p ARL4C 3.07 0.00158 -0.63 0.25561 miRNAWalker2 validate -0.11 0.00667 NA
63 hsa-miR-142-3p ARPC1A -2.4 4.0E-5 0.57 0.03866 miRanda -0.16 0 NA
64 hsa-miR-194-5p ASAP1 2.55 0.00024 -0.35 0.27587 MirTarget; miRNATAP -0.23 0 NA
65 hsa-miR-142-3p ATG4D -2.4 4.0E-5 0.16 0.62544 miRanda -0.16 3.0E-5 NA
66 hsa-miR-103a-2-5p ATP10B -2.06 0.00116 2.38 0.05795 mirMAP -0.44 0.00317 NA
67 hsa-miR-192-5p ATP10D 2.1 0.00233 -0.5 0.15756 miRNAWalker2 validate -0.14 0.00017 NA
68 hsa-miR-142-3p ATP1B1 -2.4 4.0E-5 1.43 0.00225 PITA; miRanda; miRNATAP -0.18 0.00175 NA
69 hsa-miR-192-5p ATP8B4 2.1 0.00233 -1.37 0.01009 MirTarget -0.29 0 NA
70 hsa-miR-194-5p ATP8B4 2.55 0.00024 -1.37 0.01009 MirTarget -0.28 0 NA
71 hsa-miR-200a-5p ATP8B4 2.65 1.0E-5 -1.37 0.01009 MirTarget -0.34 0 NA
72 hsa-miR-215-5p ATP8B4 3.07 0.00158 -1.37 0.01009 MirTarget -0.11 0.00536 NA
73 hsa-miR-142-3p ATRN -2.4 4.0E-5 -0.04 0.87648 miRanda -0.1 0.00261 NA
74 hsa-miR-142-3p ATXN2 -2.4 4.0E-5 0.19 0.36948 miRanda -0.12 1.0E-5 NA
75 hsa-miR-192-5p B3GALNT1 2.1 0.00233 0.12 0.70806 miRNAWalker2 validate -0.12 0.00054 NA
76 hsa-miR-141-5p BACH2 2.11 0.00092 -1.75 0.00364 miRNATAP -0.42 0 NA
77 hsa-miR-103a-2-5p BAG4 -2.06 0.00116 -0.02 0.95003 MirTarget -0.14 0.00125 NA
78 hsa-miR-103a-2-5p BARD1 -2.06 0.00116 -0.02 0.97017 MirTarget -0.17 0.02781 NA
79 hsa-miR-103a-2-5p BCAS1 -2.06 0.00116 3.1 0.00836 mirMAP -0.32 0.02129 NA
80 hsa-miR-192-5p BCL2 2.1 0.00233 -1.63 0.00261 miRNAWalker2 validate -0.31 0 26550150 MicroRNA 192 regulates chemo resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl 2; In this paper we try to test whether miR-192 regulates chemo-resistance in human carcinoma A549 mice model by targeting Bcl-2; MTT assay real-time RT-PCR western blotting assay were used to investigate miR-192 expression levels cell viability ratio and Bcl-2 protein expression levels; Bcl-2 mRNA and protein expression levels up-regulated in miR-192 inhibitor treated tumor; Bcl-2 is a key regulator for miR-192 related chemotherapy resistance; In this study we demonstrate that miR-192 regulates chemoresistance for gemcitabine and cisplatin combined chemotherapy in human adenocarcinoma lung cancer A549 cells and Bcl-2 is the target of miR-192
81 hsa-miR-200a-5p BCL2 2.65 1.0E-5 -1.63 0.00261 mirMAP -0.37 0 NA
82 hsa-miR-215-5p BCL2 3.07 0.00158 -1.63 0.00261 miRNAWalker2 validate -0.11 0.00607 NA
83 hsa-miR-192-5p BEND4 2.1 0.00233 -1.9 0.08641 mirMAP -0.36 0.00188 NA
84 hsa-miR-200a-5p BEND4 2.65 1.0E-5 -1.9 0.08641 mirMAP -0.49 0.00018 NA
85 hsa-miR-142-3p BHLHB9 -2.4 4.0E-5 0.16 0.58081 miRanda -0.12 0.0007 NA
86 hsa-miR-192-5p BHLHE22 2.1 0.00233 -0.66 0.3246 MirTarget; miRNATAP -0.43 0 NA
87 hsa-miR-215-5p BHLHE22 3.07 0.00158 -0.66 0.3246 MirTarget -0.2 5.0E-5 NA
88 hsa-miR-194-5p BICD2 2.55 0.00024 -0.53 0.06121 miRNATAP -0.24 0 NA
89 hsa-miR-194-3p BMF 2.07 0.00253 -1.61 2.0E-5 mirMAP -0.19 0 NA
90 hsa-miR-192-5p BMP2K 2.1 0.00233 -1.07 0.00527 miRNAWalker2 validate -0.11 0.00682 NA
91 hsa-miR-194-3p BMP8A 2.07 0.00253 -0.62 0.21754 MirTarget -0.24 0 NA
92 hsa-miR-103a-2-5p BMPR2 -2.06 0.00116 -0.03 0.9248 MirTarget -0.12 0.00039 NA
93 hsa-miR-194-5p BNIP2 2.55 0.00024 -0.4 0.1487 MirTarget -0.11 0.00011 NA
94 hsa-miR-142-3p BNIP3 -2.4 4.0E-5 -0.11 0.85548 miRanda -0.15 0.03481 NA
95 hsa-miR-142-3p BOD1 -2.4 4.0E-5 0.19 0.28558 miRNAWalker2 validate; MirTarget; miRanda; miRNATAP -0.12 0 NA
96 hsa-miR-142-3p BOLA1 -2.4 4.0E-5 0.2 0.53027 miRanda -0.12 0.00135 NA
97 hsa-miR-192-5p BTF3L4 2.1 0.00233 -0.07 0.72387 miRNAWalker2 validate -0.1 0 NA
98 hsa-miR-192-5p BVES 2.1 0.00233 -0.04 0.94915 mirMAP -0.21 0.001 NA
99 hsa-miR-194-3p C10orf105 2.07 0.00253 -1.54 0.0032 mirMAP -0.14 0.01047 NA
100 hsa-miR-192-5p C15orf52 2.1 0.00233 0.11 0.85147 mirMAP -0.16 0.0093 NA
101 hsa-miR-194-3p C1QTNF1 2.07 0.00253 -0.43 0.26096 mirMAP -0.13 0.00076 NA
102 hsa-miR-192-5p C1QTNF3 2.1 0.00233 -0.15 0.8394 miRNAWalker2 validate -0.27 0.0004 NA
103 hsa-miR-194-3p C20orf194 2.07 0.00253 -0.45 0.19186 miRNATAP -0.11 0.00251 NA
104 hsa-miR-192-5p CAB39L 2.1 0.00233 0.39 0.24273 miRNAWalker2 validate -0.12 0.00077 NA
105 hsa-miR-194-3p CABP7 2.07 0.00253 0.79 0.4844 mirMAP; miRNATAP -0.27 0.02249 NA
106 hsa-miR-194-3p CACHD1 2.07 0.00253 -0.83 0.06065 MirTarget; miRNATAP -0.18 0.00016 NA
107 hsa-miR-142-3p CACNA1D -2.4 4.0E-5 0.6 0.3219 miRanda -0.21 0.00465 NA
108 hsa-miR-141-5p CACNA1E 2.11 0.00092 -0.51 0.44626 mirMAP -0.43 0 NA
109 hsa-miR-200a-5p CACNA1E 2.65 1.0E-5 -0.51 0.44626 mirMAP -0.28 0.00026 NA
110 hsa-miR-142-3p CACNA2D2 -2.4 4.0E-5 0.74 0.45001 miRanda -0.32 0.00842 NA
111 hsa-miR-192-5p CADM1 2.1 0.00233 -0.53 0.36556 miRNAWalker2 validate -0.22 0.00028 NA
112 hsa-miR-194-5p CADM1 2.55 0.00024 -0.53 0.36556 miRNATAP -0.22 0.00023 NA
113 hsa-miR-103a-2-5p CADM2 -2.06 0.00116 -0.65 0.48039 mirMAP -0.3 0.0055 NA
114 hsa-miR-142-3p CALM1 -2.4 4.0E-5 0.06 0.79466 miRanda; miRNATAP -0.12 4.0E-5 NA
115 hsa-miR-141-5p CAMK1 2.11 0.00092 -0.66 0.03634 MirTarget -0.24 0 NA
116 hsa-miR-141-5p CAMK1D 2.11 0.00092 -1.41 0.01231 mirMAP -0.2 0.0022 NA
117 hsa-miR-141-5p CARD8 2.11 0.00092 -0.89 0.00259 MirTarget -0.23 0 NA
118 hsa-miR-194-5p CARD8 2.55 0.00024 -0.89 0.00259 mirMAP -0.13 2.0E-5 NA
119 hsa-miR-194-3p CAV1 2.07 0.00253 -0.35 0.54059 MirTarget -0.46 0 NA
120 hsa-miR-141-5p CBL 2.11 0.00092 -0.48 0.10129 mirMAP -0.12 0.00022 NA
121 hsa-miR-192-5p CBL 2.1 0.00233 -0.48 0.10129 mirMAP -0.13 2.0E-5 NA
122 hsa-miR-194-3p CBX6 2.07 0.00253 -0.4 0.42264 mirMAP -0.19 0.00022 NA
123 hsa-miR-142-3p CBY1 -2.4 4.0E-5 0.18 0.35088 miRanda -0.13 0 NA
124 hsa-miR-142-3p CCDC148 -2.4 4.0E-5 0.71 0.15403 miRanda -0.25 3.0E-5 NA
125 hsa-miR-192-5p CCDC18 2.1 0.00233 -0.54 0.19501 miRNAWalker2 validate -0.15 0.00058 NA
126 hsa-miR-192-5p CCDC69 2.1 0.00233 -1.15 0.05012 mirMAP -0.29 0 NA
127 hsa-miR-200a-5p CCDC88A 2.65 1.0E-5 -0.54 0.20423 miRNATAP -0.17 0.00097 NA
128 hsa-miR-142-3p CCND1 -2.4 4.0E-5 1.04 0.01709 miRanda -0.11 0.04224 23619912 Transfection of miR-142-3p mimics in colon cancer cells downregulated cyclin D1 expression induced G1 phase cell cycle arrest and elevated the sensitivity of the cells to 5-fluorouracil
129 hsa-miR-141-5p CD226 2.11 0.00092 -1.6 0.03423 MirTarget -0.44 0 NA
130 hsa-miR-192-5p CD83 2.1 0.00233 -1.46 0.00797 miRNAWalker2 validate -0.28 0 NA
131 hsa-miR-215-5p CD83 3.07 0.00158 -1.46 0.00797 miRNAWalker2 validate -0.12 0.00447 NA
132 hsa-miR-192-5p CD93 2.1 0.00233 -0.36 0.42563 MirTarget -0.27 0 NA
133 hsa-miR-215-5p CD93 3.07 0.00158 -0.36 0.42563 MirTarget -0.11 0.00149 NA
134 hsa-miR-192-5p CDC14A 2.1 0.00233 -0.8 0.05646 miRNAWalker2 validate -0.15 0.00099 NA
135 hsa-miR-194-5p CDC14A 2.55 0.00024 -0.8 0.05646 miRNATAP -0.14 0.00173 NA
136 hsa-miR-144-5p CDC42BPA -2.21 0.00517 1.03 0.00092 MirTarget -0.11 0.00024 NA
137 hsa-miR-192-5p CDCA4 2.1 0.00233 0.25 0.42479 miRNAWalker2 validate -0.11 0.0009 NA
138 hsa-miR-150-3p CDCP1 -2.15 0.0055 1.81 0.00037 MirTarget -0.22 1.0E-5 NA
139 hsa-miR-194-5p CDH2 2.55 0.00024 -0.86 0.27079 miRNAWalker2 validate; miRTarBase; miRNATAP -0.35 1.0E-5 21845495; 20979124 The results of real-time PCR and western blot highlighted that miR-194 interacted with N-cadherin and negatively regulated its expression at the translational level;The overexpression of miR-194 in liver mesenchymal-like cancer cells reduced the expression of the mesenchymal cell marker N-cadherin and suppressed invasion and migration of the mesenchymal-like cancer cells both in vitro and in vivo
140 hsa-miR-194-3p CDH23 2.07 0.00253 -1.68 0.00275 mirMAP -0.27 1.0E-5 NA
141 hsa-miR-192-5p CDK14 2.1 0.00233 -0.45 0.37362 miRNAWalker2 validate -0.35 0 NA
142 hsa-miR-194-5p CDK14 2.55 0.00024 -0.45 0.37362 MirTarget -0.33 0 NA
143 hsa-miR-215-5p CDK14 3.07 0.00158 -0.45 0.37362 miRNAWalker2 validate -0.18 0 NA
144 hsa-miR-142-3p CDKL2 -2.4 4.0E-5 -0.3 0.66224 MirTarget; miRanda -0.27 0.00122 NA
145 hsa-miR-141-5p CDO1 2.11 0.00092 -0.75 0.28667 MirTarget -0.32 6.0E-5 NA
146 hsa-miR-192-5p CDON 2.1 0.00233 -0.13 0.81496 miRNAWalker2 validate -0.36 0 NA
147 hsa-miR-194-3p CDON 2.07 0.00253 -0.13 0.81496 MirTarget -0.3 0 NA
148 hsa-miR-141-5p CDR1 2.11 0.00092 -0.32 0.68902 MirTarget -0.27 0.00269 NA
149 hsa-miR-142-3p CDS1 -2.4 4.0E-5 1.72 8.0E-5 miRanda -0.24 1.0E-5 NA
150 hsa-miR-194-3p CENPP 2.07 0.00253 0.24 0.49727 mirMAP -0.15 5.0E-5 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 CARDIOVASCULAR SYSTEM DEVELOPMENT 82 788 3.834e-14 8.92e-11
2 CIRCULATORY SYSTEM DEVELOPMENT 82 788 3.834e-14 8.92e-11
3 REGULATION OF CELL DIFFERENTIATION 121 1492 1.994e-12 3.092e-09
4 NEUROGENESIS 115 1402 3.706e-12 4.311e-09
5 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 130 1672 5.187e-12 4.827e-09
6 CELL DEVELOPMENT 112 1426 1.068e-10 7.102e-08
7 BIOLOGICAL ADHESION 89 1032 1.055e-10 7.102e-08
8 VASCULATURE DEVELOPMENT 52 469 2.296e-10 1.336e-07
9 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 109 1395 2.664e-10 1.377e-07
10 CENTRAL NERVOUS SYSTEM DEVELOPMENT 77 872 7.277e-10 3.386e-07
11 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 82 957 8.289e-10 3.506e-07
12 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 69 750 1.07e-09 3.83e-07
13 TISSUE DEVELOPMENT 114 1518 1.034e-09 3.83e-07
14 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 100 1275 1.311e-09 4.357e-07
15 REGULATION OF CELL PROJECTION ORGANIZATION 56 558 1.962e-09 5.705e-07
16 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 53 513 1.955e-09 5.705e-07
17 POSITIVE REGULATION OF NEURON DIFFERENTIATION 38 306 2.847e-09 7.791e-07
18 BLOOD VESSEL MORPHOGENESIS 42 364 3.913e-09 9.769e-07
19 POSITIVE REGULATION OF CELL DIFFERENTIATION 72 823 3.989e-09 9.769e-07
20 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 90 1142 7.596e-09 1.767e-06
21 REGULATION OF NEURON DIFFERENTIATION 54 554 1.06e-08 2.349e-06
22 CELLULAR COMPONENT MORPHOGENESIS 75 900 1.505e-08 3.183e-06
23 LOCOMOTION 87 1114 2.101e-08 4.25e-06
24 HEAD DEVELOPMENT 63 709 2.195e-08 4.256e-06
25 CELL MOTILITY 70 835 3.695e-08 6.275e-06
26 LOCALIZATION OF CELL 70 835 3.695e-08 6.275e-06
27 REGULATION OF NEURON PROJECTION DEVELOPMENT 43 408 3.776e-08 6.275e-06
28 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 81 1021 3.411e-08 6.275e-06
29 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 30 232 5.312e-08 8.524e-06
30 REGULATION OF CELL DEVELOPMENT 69 836 8.479e-08 1.315e-05
31 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 44 437 9.913e-08 1.488e-05
32 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 39 368 1.405e-07 2.043e-05
33 ACTIN FILAMENT BASED PROCESS 44 450 2.278e-07 3.211e-05
34 ANGIOGENESIS 33 293 3.203e-07 4.384e-05
35 NEURON DIFFERENTIATION 69 874 4.482e-07 5.795e-05
36 REGULATION OF CELLULAR COMPONENT MOVEMENT 63 771 4.484e-07 5.795e-05
37 REGULATION OF EPITHELIAL CELL PROLIFERATION 32 285 5.168e-07 6.499e-05
38 REGULATION OF DENDRITE DEVELOPMENT 19 120 6.736e-07 8.244e-05
39 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 33 303 6.91e-07 8.244e-05
40 TUBE DEVELOPMENT 49 552 8.605e-07 0.0001001
41 NEURON DEVELOPMENT 57 687 9.923e-07 0.0001126
42 PROTEIN LOCALIZATION 118 1805 1.07e-06 0.0001185
43 NEURAL PRECURSOR CELL PROLIFERATION 14 70 1.122e-06 0.0001215
44 MUSCLE STRUCTURE DEVELOPMENT 41 432 1.271e-06 0.0001344
45 NEURON PROJECTION MORPHOGENESIS 39 402 1.342e-06 0.0001388
46 NEURON PROJECTION DEVELOPMENT 48 545 1.391e-06 0.0001407
47 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 94 1360 1.532e-06 0.0001517
48 TISSUE MORPHOGENESIS 47 533 1.732e-06 0.0001679
49 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 76 1036 1.955e-06 0.0001779
50 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 76 1036 1.955e-06 0.0001779
51 ORGAN MORPHOGENESIS 65 841 2.017e-06 0.0001779
52 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 11 45 1.972e-06 0.0001779
53 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 73 983 2.027e-06 0.0001779
54 POSITIVE REGULATION OF CELL DEVELOPMENT 43 472 2.067e-06 0.0001781
55 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 109 1656 2.13e-06 0.0001802
56 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 13 64 2.25e-06 0.0001869
57 REGULATION OF CELLULAR COMPONENT SIZE 34 337 2.685e-06 0.0002191
58 TUBE MORPHOGENESIS 33 323 2.858e-06 0.0002293
59 MORPHOGENESIS OF AN EPITHELIUM 38 400 3.025e-06 0.0002386
60 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 16 98 3.352e-06 0.00026
61 EPITHELIUM DEVELOPMENT 70 945 3.622e-06 0.0002675
62 CYTOSKELETON ORGANIZATION 64 838 3.588e-06 0.0002675
63 HEART DEVELOPMENT 42 466 3.56e-06 0.0002675
64 REGULATION OF PHOSPHORUS METABOLIC PROCESS 106 1618 3.695e-06 0.0002687
65 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 13 67 3.864e-06 0.0002766
66 CELL PART MORPHOGENESIS 52 633 3.968e-06 0.0002797
67 RESPONSE TO ENDOGENOUS STIMULUS 97 1450 4.198e-06 0.0002915
68 TELENCEPHALON DEVELOPMENT 26 228 4.467e-06 0.0003057
69 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 13 68 4.595e-06 0.0003098
70 REGULATION OF TRANSPORT 115 1804 4.96e-06 0.0003297
71 CELL PROJECTION ORGANIZATION 67 902 5.379e-06 0.0003525
72 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 61 801 6.666e-06 0.0004308
73 REGULATION OF CELL ADHESION 51 629 7.079e-06 0.0004512
74 NEGATIVE REGULATION OF LOCOMOTION 28 263 7.346e-06 0.0004619
75 RESPONSE TO WOUNDING 47 563 7.583e-06 0.0004705
76 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 72 1008 9.265e-06 0.0005672
77 FOREBRAIN DEVELOPMENT 34 357 9.413e-06 0.0005688
78 CELL PROLIFERATION 53 672 1.028e-05 0.000613
79 REGULATION OF ANATOMICAL STRUCTURE SIZE 41 472 1.133e-05 0.0006674
80 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 60 799 1.215e-05 0.0007065
81 RESPONSE TO GROWTH FACTOR 41 475 1.317e-05 0.0007474
82 NEGATIVE REGULATION OF CELL DIFFERENTIATION 49 609 1.312e-05 0.0007474
83 NEGATIVE REGULATION OF CELL COMMUNICATION 81 1192 1.583e-05 0.0008872
84 MULTICELLULAR ORGANISMAL SIGNALING 17 123 1.676e-05 0.0009286
85 CELLULAR MACROMOLECULE LOCALIZATION 83 1234 1.794e-05 0.0009823
86 NEUROBLAST PROLIFERATION 8 29 1.927e-05 0.001043
87 CELL SUBSTRATE ADHESION 20 164 2.083e-05 0.001114
88 SECRETION 47 588 2.322e-05 0.001228
89 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 114 1848 2.386e-05 0.001247
90 COGNITION 26 251 2.491e-05 0.00126
91 REGULATION OF EPITHELIAL CELL MIGRATION 20 166 2.49e-05 0.00126
92 SKELETAL SYSTEM DEVELOPMENT 39 455 2.492e-05 0.00126
93 REGULATION OF ACTIN FILAMENT BASED PROCESS 30 312 2.593e-05 0.001267
94 CELL CELL ADHESION 48 608 2.614e-05 0.001267
95 POSITIVE REGULATION OF MOLECULAR FUNCTION 111 1791 2.539e-05 0.001267
96 CONNECTIVE TISSUE DEVELOPMENT 22 194 2.596e-05 0.001267
97 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 19 154 2.825e-05 0.001355
98 REGULATION OF TRANSMEMBRANE TRANSPORT 37 426 3.012e-05 0.00143
99 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 18 144 3.819e-05 0.001795
100 REGULATION OF PROTEIN MODIFICATION PROCESS 106 1710 3.912e-05 0.00182
101 ACTION POTENTIAL 14 94 3.953e-05 0.001821
102 SYNAPSE ORGANIZATION 18 145 4.192e-05 0.001912
103 AMINOGLYCAN BIOSYNTHETIC PROCESS 15 107 4.384e-05 0.001981
104 REGULATION OF CELL MORPHOGENESIS 44 552 4.494e-05 0.00201
105 RESPONSE TO HORMONE 63 893 4.897e-05 0.00217
106 MEMBRANE ASSEMBLY 7 25 5.82e-05 0.002555
107 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 51 689 7.879e-05 0.003426
108 TAXIS 38 464 8.355e-05 0.0036
109 REGULATION OF ENDOTHELIAL CELL MIGRATION 15 114 9.212e-05 0.003932
110 SPROUTING ANGIOGENESIS 9 45 9.34e-05 0.003951
111 SINGLE ORGANISM BEHAVIOR 33 384 9.776e-05 0.004098
112 POSITIVE REGULATION OF CELL COMMUNICATION 95 1532 0.0001006 0.004179
113 RESPONSE TO CALCIUM ION 15 115 0.0001019 0.004195
114 REGULATION OF DENDRITIC SPINE DEVELOPMENT 10 56 0.0001057 0.004228
115 POSITIVE REGULATION OF AXON EXTENSION 8 36 0.0001045 0.004228
116 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 10 56 0.0001057 0.004228
117 GLYCOPROTEIN METABOLIC PROCESS 31 353 0.0001063 0.004228
118 EMBRYONIC MORPHOGENESIS 42 539 0.0001102 0.004347
119 MUSCLE TISSUE DEVELOPMENT 26 275 0.0001157 0.004523
120 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 25 262 0.0001344 0.005212
121 SYNAPSE ASSEMBLY 11 69 0.0001405 0.005402
122 SINGLE ORGANISM CELL ADHESION 37 459 0.0001421 0.005419
123 PROTEOGLYCAN BIOSYNTHETIC PROCESS 10 58 0.0001435 0.005428
124 REGULATION OF MEMBRANE POTENTIAL 30 343 0.0001466 0.005503
125 RESPONSE TO OXYGEN LEVELS 28 311 0.0001487 0.005535
126 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 16 133 0.0001598 0.005853
127 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 21 204 0.0001591 0.005853
128 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 7 29 0.000163 0.005925
129 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 60 876 0.0001659 0.005982
130 NEURON PROJECTION GUIDANCE 21 205 0.0001704 0.006098
131 REGULATION OF CELLULAR COMPONENT BIOGENESIS 54 767 0.0001776 0.006217
132 BEHAVIOR 40 516 0.0001777 0.006217
133 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 18 162 0.0001777 0.006217
134 PROTEOGLYCAN METABOLIC PROCESS 12 83 0.0001854 0.006344
135 CELLULAR RESPONSE TO HORMONE STIMULUS 42 552 0.0001848 0.006344
136 UROGENITAL SYSTEM DEVELOPMENT 27 299 0.0001846 0.006344
137 STEM CELL PROLIFERATION 10 60 0.0001921 0.006524
138 MEMBRANE BIOGENESIS 7 30 0.0002049 0.006909
139 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 10 61 0.0002212 0.007403
140 HINDBRAIN DEVELOPMENT 16 137 0.0002258 0.007405
141 NEGATIVE REGULATION OF CELL DEVELOPMENT 27 303 0.000229 0.007405
142 POSITIVE REGULATION OF HYDROLASE ACTIVITY 61 905 0.0002254 0.007405
143 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 30 352 0.0002302 0.007405
144 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 73 1135 0.0002308 0.007405
145 REGULATION OF FILOPODIUM ASSEMBLY 8 40 0.0002286 0.007405
146 POSITIVE REGULATION OF LOCOMOTION 34 420 0.0002411 0.007638
147 AMINOGLYCAN METABOLIC PROCESS 18 166 0.0002413 0.007638
148 REGULATION OF SYSTEM PROCESS 39 507 0.0002492 0.007833
149 REGULATION OF DEVELOPMENTAL GROWTH 26 289 0.0002557 0.007984
150 PALLIUM DEVELOPMENT 17 153 0.0002661 0.008255
151 REGULATION OF CELL PROLIFERATION 91 1496 0.0002735 0.008321
152 LUNG ALVEOLUS DEVELOPMENT 8 41 0.0002736 0.008321
153 LACTATION 8 41 0.0002736 0.008321
154 POSITIVE REGULATION OF CATALYTIC ACTIVITY 92 1518 0.0002861 0.008645
155 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 22 229 0.0003017 0.009057
156 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 7 32 0.0003147 0.009387
157 GROWTH 33 410 0.000328 0.009722
158 REGULATION OF VESICLE MEDIATED TRANSPORT 36 462 0.0003337 0.009752
159 REGULATION OF ACTIN FILAMENT LENGTH 17 156 0.0003352 0.009752
160 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 25 278 0.0003354 0.009752
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOSKELETAL PROTEIN BINDING 77 819 3.86e-11 3.586e-08
2 ACTIN BINDING 44 393 4.232e-09 1.966e-06
3 CALCIUM ION BINDING 62 697 2.742e-08 8.49e-06
4 CELL ADHESION MOLECULE BINDING 26 186 8.52e-08 1.979e-05
5 PROTEIN DOMAIN SPECIFIC BINDING 55 624 2.298e-07 4.269e-05
6 MACROMOLECULAR COMPLEX BINDING 96 1399 1.605e-06 0.0002486
7 PROTEIN COMPLEX BINDING 70 935 2.502e-06 0.000332
8 GROWTH FACTOR BINDING 18 123 4.211e-06 0.000489
9 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 50 629 1.483e-05 0.001517
10 ALPHA ACTININ BINDING 7 21 1.633e-05 0.001517
11 INTEGRIN BINDING 15 105 3.5e-05 0.002956
12 GTPASE BINDING 28 295 5.994e-05 0.00464
13 CALMODULIN BINDING 20 179 7.347e-05 0.004875
14 CATION CHANNEL ACTIVITY 28 298 7.154e-05 0.004875
15 PDZ DOMAIN BINDING 13 90 0.0001022 0.006328
16 ENZYME BINDING 105 1737 0.0001146 0.006653
17 VOLTAGE GATED ION CHANNEL ACTIVITY 20 190 0.0001673 0.007773
18 STEROID HORMONE RECEPTOR ACTIVITY 10 59 0.0001663 0.007773
19 ACTININ BINDING 7 29 0.000163 0.007773
20 RAB GTPASE BINDING 15 120 0.0001653 0.007773
21 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 34 417 0.000211 0.009332
NumGOOverlapSizeP ValueAdj. P Value
1 CELL PROJECTION 136 1786 6.823e-12 3.984e-09
2 CELL JUNCTION 97 1151 5.073e-11 1.481e-08
3 NEURON PART 103 1265 8.803e-11 1.714e-08
4 NEURON PROJECTION 83 942 1.67e-10 2.439e-08
5 CELL PROJECTION PART 78 946 1.208e-08 1.411e-06
6 SYNAPSE 66 754 1.794e-08 1.746e-06
7 CELL LEADING EDGE 39 350 3.675e-08 3.066e-06
8 SOMATODENDRITIC COMPARTMENT 57 650 1.636e-07 1.194e-05
9 CELL SURFACE 63 757 2.366e-07 1.535e-05
10 LAMELLIPODIUM 24 172 2.75e-07 1.606e-05
11 ANCHORING JUNCTION 45 489 9.106e-07 4.834e-05
12 ACTIN CYTOSKELETON 41 444 2.543e-06 0.0001238
13 DENDRITE 41 451 3.754e-06 0.0001687
14 MEMBRANE REGION 79 1134 8.37e-06 0.0003492
15 FILOPODIUM 15 94 9.003e-06 0.0003505
16 SYNAPSE PART 49 610 1.37e-05 0.0005002
17 CATION CHANNEL COMPLEX 20 167 2.718e-05 0.0009338
18 GOLGI APPARATUS PART 63 893 4.897e-05 0.001505
19 PLASMA MEMBRANE REGION 65 929 4.761e-05 0.001505
20 SITE OF POLARIZED GROWTH 18 149 6.024e-05 0.001759
21 CELL SUBSTRATE JUNCTION 34 398 8.661e-05 0.002409
22 INTRINSIC COMPONENT OF PLASMA MEMBRANE 101 1649 9.573e-05 0.002541
23 CYTOSKELETON 116 1967 0.0001347 0.003421
24 CELL BODY 39 494 0.0001466 0.003567
25 INTRACELLULAR VESICLE 80 1259 0.0001702 0.003976
26 NEURON SPINE 15 121 0.0001815 0.004077
27 CELL CELL JUNCTION 32 383 0.0002072 0.00442
28 GOLGI APPARATUS 89 1445 0.0002119 0.00442
29 ACTIN BASED CELL PROJECTION 19 181 0.00025 0.005034
30 EXTRACELLULAR MATRIX COMPONENT 15 125 0.0002606 0.005073
31 POSTSYNAPSE 31 378 0.0003571 0.006726
32 CELL CELL ADHERENS JUNCTION 9 54 0.0003989 0.00728
33 SECRETORY GRANULE MEMBRANE 11 78 0.0004243 0.007509
34 AXON 33 418 0.0004622 0.00794
35 BASEMENT MEMBRANE 12 93 0.0005425 0.008932
36 PLASMA MEMBRANE PROTEIN COMPLEX 38 510 0.0005506 0.008932

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04916_Melanogenesis 14 101 8.853e-05 0.00686
2 hsa04390_Hippo_signaling_pathway 18 154 9.286e-05 0.00686
3 hsa04810_Regulation_of_actin_cytoskeleton 22 214 0.0001143 0.00686
4 hsa04512_ECM.receptor_interaction 12 85 0.0002332 0.008441
5 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 6 22 0.0002345 0.008441
6 hsa04014_Ras_signaling_pathway 22 236 0.0004577 0.01373
7 hsa04514_Cell_adhesion_molecules_.CAMs. 15 136 0.0006471 0.01521
8 hsa04310_Wnt_signaling_pathway 16 151 0.0006758 0.01521
9 hsa04020_Calcium_signaling_pathway 17 177 0.001408 0.02815
10 hsa04151_PI3K_AKT_signaling_pathway 27 351 0.00212 0.03515
11 hsa04510_Focal_adhesion 18 200 0.002148 0.03515
12 hsa04912_GnRH_signaling_pathway 11 101 0.003609 0.05137
13 hsa04270_Vascular_smooth_muscle_contraction 12 116 0.00371 0.05137
14 hsa04730_Long.term_depression 8 70 0.009238 0.1188
15 hsa04971_Gastric_acid_secretion 8 74 0.01274 0.1451
16 hsa04970_Salivary_secretion 9 89 0.0129 0.1451
17 hsa04010_MAPK_signaling_pathway 19 268 0.01988 0.2105
18 hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate 4 26 0.02264 0.2264
19 hsa04972_Pancreatic_secretion 9 101 0.02724 0.2581
20 hsa04520_Adherens_junction 7 73 0.03444 0.31
21 hsa04666_Fc_gamma_R.mediated_phagocytosis 8 95 0.04796 0.4031
22 hsa04360_Axon_guidance 10 130 0.04926 0.4031
23 hsa00510_N.Glycan_biosynthesis 5 49 0.05519 0.4192
24 hsa04530_Tight_junction 10 133 0.05589 0.4192
25 hsa00565_Ether_lipid_metabolism 4 36 0.06424 0.4625
26 hsa04350_TGF.beta_signaling_pathway 7 85 0.0682 0.4722
27 hsa04710_Circadian_rhythm_._mammal 3 23 0.07124 0.4749
28 hsa04976_Bile_secretion 6 71 0.07951 0.5112
29 hsa04960_Aldosterone.regulated_sodium_reabsorption 4 42 0.1005 0.624
30 hsa04114_Oocyte_meiosis 8 114 0.1103 0.6514
31 hsa04070_Phosphatidylinositol_signaling_system 6 78 0.1122 0.6514
32 hsa00603_Glycosphingolipid_biosynthesis_._globo_series 2 14 0.1163 0.6541
33 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 2 15 0.1306 0.7122
34 hsa04330_Notch_signaling_pathway 4 47 0.1365 0.7228
35 hsa04012_ErbB_signaling_pathway 6 87 0.1626 0.836
36 hsa04720_Long.term_potentiation 5 70 0.1741 0.8362
37 hsa00670_One_carbon_pool_by_folate 2 18 0.1754 0.8362
38 hsa04062_Chemokine_signaling_pathway 11 189 0.1783 0.8362
39 hsa04540_Gap_junction 6 90 0.1812 0.8362
40 hsa04130_SNARE_interactions_in_vesicular_transport 3 36 0.1941 0.8734
41 hsa04340_Hedgehog_signaling_pathway 4 56 0.2117 0.9294
42 hsa01040_Biosynthesis_of_unsaturated_fatty_acids 2 21 0.2223 0.9525
43 hsa04910_Insulin_signaling_pathway 8 138 0.23 0.9627
44 hsa04146_Peroxisome 5 79 0.2421 0.9904
45 hsa00564_Glycerophospholipid_metabolism 5 80 0.2501 1
46 hsa04141_Protein_processing_in_endoplasmic_reticulum 9 168 0.2817 1
47 hsa04962_Vasopressin.regulated_water_reabsorption 3 44 0.2849 1
48 hsa04973_Carbohydrate_digestion_and_absorption 3 44 0.2849 1
49 hsa04320_Dorso.ventral_axis_formation 2 25 0.2858 1
50 hsa04914_Progesterone.mediated_oocyte_maturation 5 87 0.3074 1
51 hsa00030_Pentose_phosphate_pathway 2 27 0.3175 1
52 hsa04115_p53_signaling_pathway 4 69 0.3341 1
53 hsa00512_Mucin_type_O.Glycan_biosynthesis 2 30 0.3643 1
54 hsa04670_Leukocyte_transendothelial_migration 6 117 0.3748 1
55 hsa04150_mTOR_signaling_pathway 3 52 0.3784 1
56 hsa04742_Taste_transduction 3 52 0.3784 1
57 hsa00260_Glycine._serine_and_threonine_metabolism 2 32 0.3948 1
58 hsa04370_VEGF_signaling_pathway 4 76 0.4019 1
59 hsa00240_Pyrimidine_metabolism 5 99 0.4086 1
60 hsa04260_Cardiac_muscle_contraction 4 77 0.4115 1
61 hsa04974_Protein_digestion_and_absorption 4 81 0.4496 1
62 hsa04722_Neurotrophin_signaling_pathway 6 127 0.4506 1
63 hsa00051_Fructose_and_mannose_metabolism 2 36 0.4537 1
64 hsa00270_Cysteine_and_methionine_metabolism 2 36 0.4537 1
65 hsa03015_mRNA_surveillance_pathway 4 83 0.4683 1
66 hsa04630_Jak.STAT_signaling_pathway 7 155 0.4846 1
67 hsa04640_Hematopoietic_cell_lineage 4 88 0.5141 1
68 hsa04210_Apoptosis 4 89 0.523 1
69 hsa00230_Purine_metabolism 7 162 0.5314 1
70 hsa02010_ABC_transporters 2 44 0.5608 1
71 hsa04610_Complement_and_coagulation_cascades 3 69 0.5633 1
72 hsa03050_Proteasome 2 45 0.5731 1
73 hsa04144_Endocytosis 8 203 0.631 1
74 hsa04145_Phagosome 6 156 0.651 1
75 hsa04664_Fc_epsilon_RI_signaling_pathway 3 79 0.6551 1
76 hsa00330_Arginine_and_proline_metabolism 2 54 0.6723 1
77 hsa00562_Inositol_phosphate_metabolism 2 57 0.701 1
78 hsa00590_Arachidonic_acid_metabolism 2 59 0.7189 1
79 hsa04621_NOD.like_receptor_signaling_pathway 2 59 0.7189 1
80 hsa00830_Retinol_metabolism 2 64 0.7598 1
81 hsa04920_Adipocytokine_signaling_pathway 2 68 0.7887 1
82 hsa04380_Osteoclast_differentiation 4 128 0.7954 1
83 hsa04662_B_cell_receptor_signaling_pathway 2 75 0.8319 1
84 hsa04612_Antigen_processing_and_presentation 2 78 0.8479 1
85 hsa03013_RNA_transport 3 152 0.9583 1
86 hsa04142_Lysosome 2 121 0.9664 1
87 hsa04110_Cell_cycle 2 128 0.974 1
88 hsa04650_Natural_killer_cell_mediated_cytotoxicity 2 136 0.9807 1
89 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.9827 1
90 hsa04740_Olfactory_transduction 4 388 1 1

Quest ID: cd54af3f8d210f6bfe4118b9df7bf573